GlobeNewswire, Inc.

Increased 2026 revenue guidance from $510 million to $525 million Achieved record-high quarterly revenues, Adjusted EBITDA1 and Adjusted EBITDA per share1 since inception MONTREAL, May 07, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:...

EIN Presswire

A Practical Solution For America’s Rural & Small Hospitals YARDLEY, PA, UNITED STATES, April 30, 2026 /⁨EINPresswire.com⁩/ -- There is an epidemic in health care in America, where the hospital itself, specifically rural and small hospitals, have...

GlobeNewswire, Inc.

Geneva, Switzerland, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Today, at the 158th Executive Board meeting of the World Health Organization (WHO), Member States agreed to include the draft resolution “Steatotic liver disease: a missing piece in the global...

GlobeNewswire, Inc.

Boston, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) is rapidly transforming how clinical trials are designed, conducted and monitored, bringing automation, predictive insights and real-time decision support into every phase of...

GlobeNewswire, Inc.

AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related peptide (CGRP) antagonist treatment option for both pediatric and adult patients.1,2 Results from the SPACE trial...

EIN Presswire

Expanded collaboration significantly broadens ACA Pharma’s ex-U.S. commercialization footprint for RYANODEX® NEW YORK, NY, UNITED STATES, November 24, 2025 /⁨EINPresswire.com⁩/ -- ACA Pharma today announced a significant expansion of their...